ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,970.84
-1.11%
US Tech 100
20,897.20
-1.35%
다우존스 지수
42,992.21
-0.77%
Bitcoin
93,501.34
-1.72%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. ChampionX Corporation (CHX)

  7. ChampionX Corporation (CHX) 뉴스

ChampionX Corporation

ChampionX Corporation (CHX)

NASDAQ
26.64
-0.04
(-0.15%)
마감 30 12월 6:00AM
15분 지연
26.66
0.02
(0.08%)
시간외 거래: 7:57AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

CHX 뉴스

공식 뉴스 전용

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 12월 2024
CHX (-0.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CHX (-0.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CHX (-0.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 11월 2024
CHX (-0.15%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 11월 2024
CHX (-0.15%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
25 10월 2024
CHX (-0.15%)

Form 8-K - Current report
Edgar (US Regulatory)
24 10월 2024
CHX (-0.15%)

토론

전체 피드 보기
3331 3331 5 분 전
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
Stock_Barber Stock_Barber 5 분 전
It's just common sense!
Well, that quickly eliminates most DBMM shareholders!
DBMM
redspinelpinktopaz redspinelpinktopaz 5 분 전
the denominator goes on the bottom. Lebby goes on the top
LWLG
3331 3331 5 분 전
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
Chartmaster Chartmaster 5 분 전
OTC 2025 Gold Rush coming!!!!!
GRLT
Mr. Dragon Mr. Dragon 6 분 전
Not necessarily....many otc ceo's will use the crutch of being incompetant instead of being malicious. Most, of course, are indeed malicious but there is a legal, fine line, between the two that the crooks take advantage of. They have to be proven malicious to be charged with anything at all. The
DPLS
Pnypnchr Pnypnchr 6 분 전
Yes only the lying minority are here 24/7 with their noses up in everyone's business where it don't belong.
ColdDarkHole ColdDarkHole 6 분 전
When does everything come due on our debt after we shoved everything off? How much does our next dilutive loan shark deal need to be to keep the tip of the company's nose above water? What are the bonuses this year 🤔?
NB
Chartmaster Chartmaster 7 분 전
It's been going up because of Well, as long as you agree this ticker is going up, that's all that matters! Lol!
GRLT
JonDoe1 JonDoe1 8 분 전
Gravel gets hauled all the time for a profit. Try again B Squad.
AABB
bas2020 bas2020 10 분 전
How much does it pay to work FUD on a Sunday?
NWBO
Chartmaster Chartmaster 10 분 전
Nice post! Thanks!
GRLT
Chartmaster Chartmaster 12 분 전
Agree! After Christmas is when this ticker exploded in 2020
PHIL
Hardazoak Hardazoak 12 분 전
For gravel is impossible. The cost of fuel is 10 X more than cost of gravel. Try another lie. Can't wait.
AABB
delerious1 delerious1 12 분 전
I don't know about all that other stuff, no-one does but I do know that since JL took over as CEO in February things have been very good and moving quickly in the right direction.....and the shareprice is okay as well. We have a Mill and a few goldmines as well...and record Spot Gold prices....the p
NBRI
Poo28 Poo28 14 분 전
DBMM is fully reporting and fully compliant. All regulators support DBMM’s potential and business which is executing the growth plan for the future. The SEC says Ignore these guys. No standing.

DBMM always prevails, the OIP Dismissal says in all. Tenacity and reality win the day. Go
DBMM OTCM
OMOLIVES OMOLIVES 14 분 전
I've used baking soda and lime juice in the past. Usually I am a little too buzzed to bother with such at night and say f' it :) I used to have an issue with nachos @ night...lol.
bas2020 bas2020 15 분 전
The company has over 5 years of detailed spoofing evidence. Go look it up...
NWBO
dstock07734 dstock07734 15 분 전
EX,

Why did they change the start date of the following trial with RevImmune as collaborator into the end of January? Is it coincidental?

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After
NWBO
Hardazoak Hardazoak 15 분 전
I heard the stockpile would last 20 years +
AABB
noradio noradio 15 분 전
I actually think the OTC is just starting another bull run that will dwarf the one in 20-21. What we saw recently with HMBL was just a taste of what's to come, this person explains it well...

https://x.com/ChartDiligence/status/1865056526416908756

https://x.com/ChartDil
HMBL
Poo28 Poo28 16 분 전
Hope real shareholders had Happy Holidays and a very Merry Christmas. We all share support for the future and the growth and launch of A1 products. The pivot to the future in tech model from beta to offering, is incredibly promising and will ensure DBMM’s best year in 2025. As a reminder, here is th
DBMM
Monksdream Monksdream 16 분 전
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufa
ADMA

최근 히스토리

NASDAQ
CHX
ChampionX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유